Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Instanyl

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Rapid acting fentanyl formulations in breakthrough pain in cancer. Drug selection by means of the System of Objectified Judgement Analysis
Drug selection of rapid acting fentanyl formulations in the treatment of breakthrough pain in patients with cancer is performed… Expand
2014
2014
The use of Instanyl® in the treatment of breakthrough pain in cancer patients: a 3-month observational, prospective, cohort study
PurposeInstanyl® (intranasal fentanyl spray) is a novel treatment for breakthrough pain (BTP) in cancer patients. It has shown a… Expand
  • table 1
  • table 1
  • figure 1
  • table 2
  • table 3
2014
2014
Efficiency of Intranasal Fentanyl in Patients with Breakthrough Cancer Pain in Daily Practice - Results of the German Non-Interventional Study with Instanyl® (GENISIS)
Objective: Breakthrough cancer pain (BTcP) affects 19-95% of cancer patients (dependent on the definition and methods used and… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
2013
2013
Evidence-based treatment of cancer-related breakthrough pain with opioids.
  • G. Zeppetella
  • Journal of the National Comprehensive Cancer…
  • 2013
    • Corpus ID: 42160197
Opioids are considered important analgesics in the treatment armamentarium for moderate-to-severe background cancer pain. The… Expand
2013
2013
Resultados en salud y eficiencia del fentanilo intranasal en pectina en el dolor irruptivo en la práctica clínica habitual
Objective: Determine, with a pharmacoeconomic evaluation, the effectiveness and efficiency of fentanyl pectin intranasal spray… Expand
Highly Cited
2012
Highly Cited
2012
Nasal drug delivery
The nasal cavity has for more than three decades been widely explored as a potential alternative route to oral or parenteral… Expand
  • figure 1
2012
2012
Mise au point sur l’utilisation du fentanyl transmuqueux chez le patient présentant des douleurs d’origine cancéreuse
1 Polyclinique de l’Ormeau, Tarbes. 2 Hôpital André-Mignot, Le Chesnay. 3 Institut Paoli-Calmette, Marseille. 4 CH de Bayeux. 5… Expand
2012
2012
Nasal delivery of fentanyl
Fentanyl, a potent opioid analgesic, is rapidly and efficiently absorbed from the nasal cavity, giving significant potential for… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
Review
2011
Review
2011
Newer Generation Fentanyl Transmucosal Products for Breakthrough Pain in Opioid-Tolerant Cancer Patients
Oral normal-release morphine has long been considered the gold-standard treatment for cancer breakthrough pain. However, its… Expand
  • table I
  • table II
  • table II
  • figure 1
  • figure 2
Review
2010
Review
2010
Instanyl: intranasal fentanyl for treating breakthrough pain
Instanyl is an intranasal formulation of fentanyl licensed for breakthrough pain management in chronic cancer pain. In our New… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE